Gerresheimer AG Logo

Gerresheimer AG

Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-20 13:18
Board/Management Information
Gerresheimer AG: Change in the Supervisory Board
English 9.3 KB
2025-11-19 18:38
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-18 10:02
Environmental & Social Information
Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
English 13.3 KB
2025-11-17 17:11
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-11-12 18:26
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-10 16:10
Declaration of Voting Results & Voting Rights Announcements
English 16.8 KB
2025-11-06 11:32
Declaration of Voting Results & Voting Rights Announcements
English 14.3 KB
2025-11-03 11:36
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-10-31 11:32
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-30 10:54
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-29 10:40
Declaration of Voting Results & Voting Rights Announcements
English 16.0 KB
2025-10-28 16:10
Board/Management Information
Gerresheimer: Uwe Rohrhoff takes over as interim CEO for Dietmar Siemssen
English 10.5 KB
2025-10-27 10:05
Declaration of Voting Results & Voting Rights Announcements
English 14.9 KB
2025-10-25 19:24
Legal Proceedings Report
Gerresheimer AG: Initial findings of an external independent investigation into…
English 7.9 KB
2025-10-23 21:12
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gerresheimer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan
7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany
AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Adagio Medical Holdings, Inc. Logo
Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.
United States of America
ADGM
Advanced Biomed Inc. Logo
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America
ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.
United States of America
AEMD
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France
AFME
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America
AIMD
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea
447690

Talk to a Data Expert

Have a question? We'll get back to you promptly.